Congenital neutropenia

DBCOND0020521Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesDiagnostic Techniques and Procedures

Congenital neutropenia is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT743101ICD-10D70.0SNOMED CT191342002MedDRA10052210UMLSC0340970

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Congenital neutropenia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In